First, by performing an integrative study of the regulatory programs of GBM, MB, NB and the developing brain, we find that SPI1 and IRF8 are candidate regulators of the mesenchymal shift induced by TAMs and/or microglia in GBM. The gene discussed is IRF8; the disease is neuroblastoma.